Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 121

Sort by

Sort Order Select

Journal Articles

Pharmacological targeting of CTPS1 elicits macrophage-mediated anti-leukemia immunity

Meng Liu, Lei Zhang, Xin He, Haojie Dong, Yang Li, Shuaishuai Ge, Guohua Wu, Umesh Yadav, wei chen, Pinghui Feng, Guido Marcucci, Ling Li

Blood (2025) 146 (Supplement 1): 1490.

https://doi.org/10.1182/blood-2025-1490

Published: 2025

Journal Articles

Targeting the METTL1/m7G axis as a therapeutic strategy in myeloid leukemia

Blood (2025) 146 (Supplement 1): 2539.

https://doi.org/10.1182/blood-2025-2539

Published: 2025

Journal Articles

Venetoclax with hypomethylating agents versus intensive chemotherapy as induction therapy in patients with newly diagnosed acute monocytic leukemia

Yi Wang, Ling Li, Shijia Li, Yanli Feng, Tongxia Lu, Aaron Lobo

Blood (2025) 146 (Supplement 1): 6976.

https://doi.org/10.1182/blood-2025-6976

Published: 2025

Journal Articles

Venetoclax combined with three-day multi-frequency decitabine, vincristine and dexamethasone (VDVD) as induction treatment for patients with de novo acute leukaemias of ambiguous lineage

Xingli Zhao, Xiaohui SUO, Guanchen Bai, Yanliang Bai, Fang Zheng, Jie Liu, Ling Li, Yingchang Mi, Kaiqi Liu

Blood (2025) 146 (Supplement 1): 3451.

https://doi.org/10.1182/blood-2025-3451

Published: 2025

Journal Articles

Targeting PRMT7 enhances the anti-AML immunity by regulating MHC-I

Shuaishuai Ge, Kaixiu luo, Lei Zhang, Meng Liu, Xin He, Guohua Wu, Yang Li, Umesh Yadav, Haojie Dong, Shengli Xue, Jian Jin, Ling Li

Blood (2025) 146 (Supplement 1): 387.

https://doi.org/10.1182/blood-2025-387

Published: 2025

Journal Articles

A multicenter phase 1 trial evaluating the safety and preliminary efficacy of revumenib as post-transplant maintenance after allogeneic hematopoietic cell transplant in patients with KMT2A-rearranged or NPM1-mutated acute leukemia

Brian Ball, Mahasweta Gooptu, Ling Li, Christopher Hourigan, Sally Mokhtari, Dongyun Yang, Leonardo Farol, Yazeed Samara, Anthony Selwyn Stein, Guido Marcucci, Monzr M. Al Malki, Corey Cutler, Ryotaro Nakamura, Ibrahim Aldoss

Blood (2025) 146 (Supplement 1): 5207.

https://doi.org/10.1182/blood-2025-5207

Published: 2025

Journal Articles

Targeting adss overcomes venetoclax resistance in TP53-mutated acute myeloid leukemia

Blood (2025) 146 (Supplement 1): 213.

https://doi.org/10.1182/blood-2025-213

Published: 2025

Journal Articles

DDX6 undergoes phase separation to modulate metabolic plasticity and chemoresistance

Blood (2025) 146 (Supplement 1): 212.

https://doi.org/10.1182/blood-2025-212

Published: 2025

Journal Articles

Mitochondrial RNA pseudouridine reprograms metabolism and induces immunosuppression in myeloid leukemia

Blood (2025) 146 (Supplement 1): 211.

https://doi.org/10.1182/blood-2025-211

Published: 2025

Journal Articles

Mitochondrial RNA Methylation By METTL17 Rewires Metabolism and Regulates Retrograde Mitochondrial-Nuclear Communication in AML

Blood (2024) 144 (Supplement 1): 625.

https://doi.org/10.1182/blood-2024-201916

Published: 2024

Journal Articles

Outcomes and Prognostic Factors of the Alternative Regimens for Angioimmunoblastic T Cell Lymphoma: A Retrospective Study

Jiaqin Yan, Bingjie Wang, Yankui Wei, Shasha Zhang, Lei Zhang, Ling Li, Xin Li, Xiaorui Fu, Xinhua Wang, Zhenchang Sun, Xudong Zhang, Mingzhi Zhang

Blood (2024) 144 (Supplement 1): 6408.

https://doi.org/10.1182/blood-2024-206732

Published: 2024

Journal Articles

Targeting PRMT9 Overcomes Venetoclax Resistance in AML By Modulating Splicing and Inhibiting Translation

Yang Li, Xin He, Haojie Dong, Lei Zhang, Umesh Yadav, Meng Liu, Lianjun Zhang, Guido Marcucci, Shaoyuan Wang, Ling Li

Blood (2024) 144 (Supplement 1): 54.

https://doi.org/10.1182/blood-2024-203923

Published: 2024

Journal Articles

7-Day Venetoclax Combined with Intensive Chemotherapy As Induction Treatment in Newly Diagnosed Acute Myeloid Leukemia

Blood (2024) 144 (Supplement 1): 2885.

https://doi.org/10.1182/blood-2024-198844

Published: 2024

Journal Articles

Strikingly Reduced Toxicities of Fotemustine-Based Chemotherapeutics Than High-Dose Methotrexate-Containing Regimens with Comparable Efficacy

Blood (2024) 144 (Supplement 1): 6458.

https://doi.org/10.1182/blood-2024-202107

Published: 2024

Journal Articles

Targeting Cytidine Triphosphate Synthase 1 Promotes Anti-AML Immunity

Meng Liu, Lei Zhang, Haojie Dong, Xin He, Yang Li, Umesh Yadav, Guido Marcucci, Ling Li

Blood (2024) 144 (Supplement 1): 3590.

https://doi.org/10.1182/blood-2024-203905

Published: 2024

Journal Articles

Venetoclax Combined with Intensive Chemotherapy As an Induction Chemotherapy in Newly Diagnosed FLT3-ITD Positive AML

Blood (2024) 144 (Supplement 1): 1485.

https://doi.org/10.1182/blood-2024-203422

Published: 2024

Journal Articles

High HDAC8 Creates Targetable Vulnerabilities in Acute Myeloid Leukemia through Dysregulation of BRCA1-Related RNA Splicing Machinery and Defective DNA Damage Repair

Lianjun Zhang, Yu-Hsuan Fu, Wei-Kai Hua, Le Xuan Truong Nguyen, Xin He, Wancheng Guo, Yinghui Zhu, Ying-Chieh Chen, Zhenhua Chen, Haojie Dong, Lei Zhang, Bin Zhang, Jeremy Stark, Ling Li, Guido Marcucci, Ya-Huei Kuo

Blood (2024) 144 (Supplement 1): 1398.

https://doi.org/10.1182/blood-2024-208137

Published: 2024

Journal Articles

A CD38-directed, single-chain T-cell engager targets leukemia stem cells through IFN-γ–induced CD38 expression

Blood (2024) 143 (16): 1599–1615.

https://doi.org/10.1182/blood.2023021570

Published: 2024

Includes: Supplemental data

Journal Articles

CD19/BCMA Dual-Targeting Fastcar-T GC012F for Patients with Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma: An Update

Xinfeng Chen, Yu Ping, Ling Li, Lei Zhang, Xudong Zhang, Jianmin Huang, Jia Liu, Gui Li, Huan Shi, Jiaping He, Yi Liang, Lihong Weng, Wenjie Yin, Lianjun Shen, Wei William Cao, Wenling Li, Mingzhi Zhang, Yi Zhang

Blood (2023) 142 (Supplement 1): 6847.

https://doi.org/10.1182/blood-2023-185476

Published: 2023

Journal Articles

Targeting ADSS2 Enhances BH3 Mimetics Treatment Induced Mitochondrial Apoptosis in AML Cells

Xin He, Lei Zhang, Yang Li, Haojie Dong, Lianjun Zhang, Daisuke Nakada, Guido Marcucci, Yun Luo, Ling Li

Blood (2023) 142 (Supplement 1): 577.

https://doi.org/10.1182/blood-2023-186907

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Pharmacological targeting of CTPS1 elicits macrophage-mediated anti-leukemia immunity

Targeting the METTL1/m7G axis as a therapeutic strategy in myeloid leukemia

Venetoclax with hypomethylating agents versus intensive chemotherapy as induction therapy in patients with newly diagnosed acute monocytic leukemia

Venetoclax combined with three-day multi-frequency decitabine, vincristine and dexamethasone (VDVD) as induction treatment for patients with de novo acute leukaemias of ambiguous lineage

Targeting PRMT7 enhances the anti-AML immunity by regulating MHC-I

A multicenter phase 1 trial evaluating the safety and preliminary efficacy of revumenib as post-transplant maintenance after allogeneic hematopoietic cell transplant in patients with KMT2A-rearranged or NPM1-mutated acute leukemia

Targeting adss overcomes venetoclax resistance in TP53-mutated acute myeloid leukemia

DDX6 undergoes phase separation to modulate metabolic plasticity and chemoresistance

Mitochondrial RNA pseudouridine reprograms metabolism and induces immunosuppression in myeloid leukemia

Mitochondrial RNA Methylation By METTL17 Rewires Metabolism and Regulates Retrograde Mitochondrial-Nuclear Communication in AML

Outcomes and Prognostic Factors of the Alternative Regimens for Angioimmunoblastic T Cell Lymphoma: A Retrospective Study

Targeting PRMT9 Overcomes Venetoclax Resistance in AML By Modulating Splicing and Inhibiting Translation

7-Day Venetoclax Combined with Intensive Chemotherapy As Induction Treatment in Newly Diagnosed Acute Myeloid Leukemia

Strikingly Reduced Toxicities of Fotemustine-Based Chemotherapeutics Than High-Dose Methotrexate-Containing Regimens with Comparable Efficacy

Targeting Cytidine Triphosphate Synthase 1 Promotes Anti-AML Immunity

Venetoclax Combined with Intensive Chemotherapy As an Induction Chemotherapy in Newly Diagnosed FLT3-ITD Positive AML

High HDAC8 Creates Targetable Vulnerabilities in Acute Myeloid Leukemia through Dysregulation of BRCA1-Related RNA Splicing Machinery and Defective DNA Damage Repair

A CD38-directed, single-chain T-cell engager targets leukemia stem cells through IFN-γ–induced CD38 expression

CD19/BCMA Dual-Targeting Fastcar-T GC012F for Patients with Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma: An Update

Targeting ADSS2 Enhances BH3 Mimetics Treatment Induced Mitochondrial Apoptosis in AML Cells

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only